173 related articles for article (PubMed ID: 12023140)
1. Adjuvant whole abdominal radiotherapy in epithelial cancer of the ovary.
Hepp R; Baeza MR; Olfos P; Suarez E
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):360-5. PubMed ID: 12023140
[TBL] [Abstract][Full Text] [Related]
2. High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes.
Firat S; Murray K; Erickson B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):201-7. PubMed ID: 12909234
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study.
Arians N; Kieser M; Benner L; Rochet N; Schröder L; Katayama S; Herfarth K; Schubert K; Schneeweiss A; Sohn C; Lindel K; Debus J
Radiat Oncol; 2019 Oct; 14(1):179. PubMed ID: 31639066
[TBL] [Abstract][Full Text] [Related]
4. Whole abdominal irradiation in endometrial cancer - a single institution study.
Gocheva L; Slavchev B
J BUON; 2009; 14(4):613-8. PubMed ID: 20148451
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Intensity Modulated Whole-Abdominal Radiation Therapy for High-Risk Patients With Ovarian Cancer (International Federation of Gynecology and Obstetrics Stage III): First Results of a Prospective Phase 2 Study.
Arians N; Kieser M; Benner L; Rochet N; Katayama S; Sterzing F; Herfarth K; Schubert K; Schröder L; Leitzen C; Schneeweiss A; Sohn C; Debus J; Lindel K
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):912-920. PubMed ID: 28870790
[TBL] [Abstract][Full Text] [Related]
6. A randomized study of two doses of abdominopelvic radiation therapy for patients with optimally debulked Stage I, II, and III ovarian cancer.
Fyles AW; Thomas GM; Pintilie M; Ackerman I; Levin W
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):543-9. PubMed ID: 9635700
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
8. Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma.
MacGibbon A; Bucci J; MacLeod C; Solomon J; Dalrymple C; Firth I; Carter J
Gynecol Oncol; 1999 Oct; 75(1):62-7. PubMed ID: 10502427
[TBL] [Abstract][Full Text] [Related]
9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of whole abdominal irradiation in ovarian carcinoma with a four orthogonal fields technique.
Thomas L; Pigneux J; Chauvergne J; Stöckle E; Bussières E; Chemin A; Toulouse C
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1083-90. PubMed ID: 7961015
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival with whole abdominopelvic irradiation in platinum-refractory persistent or recurrent ovarian cancer.
Cmelak AJ; Kapp DS
Gynecol Oncol; 1997 Jun; 65(3):453-60. PubMed ID: 9190975
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer : four-year outcomes.
Rochet N; Lindel K; Katayama S; Schubert K; Herfarth K; Schneeweiss A; Sohn C; Harms W; Debus J
Strahlenther Onkol; 2015 Jul; 191(7):582-9. PubMed ID: 25786589
[TBL] [Abstract][Full Text] [Related]
13. Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer.
Engelen MJA; Snel BJ; Schaapveld M; Pras E; de Vries EGE; Gietema JA; van der Zee AGJ; Willemse PHB
Eur J Cancer; 2009 May; 45(7):1193-1200. PubMed ID: 19201598
[TBL] [Abstract][Full Text] [Related]
14. Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III--the OVAR-IMRT-02 Study.
Rochet N; Kieser M; Sterzing F; Krause S; Lindel K; Harms W; Eichbaum MH; Schneeweiss A; Sohn C; Debus J
BMC Cancer; 2011 Jan; 11():41. PubMed ID: 21276234
[TBL] [Abstract][Full Text] [Related]
15. Results of post-operative abdomino-pelvic radiotherapy in intermediate- and high-risk epithelial ovarian carcinoma.
Mosalaei A; Kazerooni T
Eur J Cancer Care (Engl); 2008 Jul; 17(4):371-6. PubMed ID: 18537815
[TBL] [Abstract][Full Text] [Related]
16. Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer.
Pickel H; Lahousen M; Petru E; Stettner H; Hackl A; Kapp K; Winter R
Gynecol Oncol; 1999 Feb; 72(2):215-9. PubMed ID: 10021304
[TBL] [Abstract][Full Text] [Related]
17. [Tolerance and role of irradiation in the treatment of epithelial cancer of the ovary].
Quétin P; Marchal C; Hoffstetter S; Cutuli B; Beckendorf V; Lapeyre M; Peiffert D; Bey P
Cancer Radiother; 1998; 2(4):366-74. PubMed ID: 9755750
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study.
Rochet N; Sterzing F; Jensen AD; Dinkel J; Herfarth KK; Schubert K; Eichbaum MH; Schneeweiss A; Sohn C; Debus J; Harms W
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1382-9. PubMed ID: 19628341
[TBL] [Abstract][Full Text] [Related]
19. Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.
Stewart KD; Martinez AA; Weiner S; Podratz K; Stromberg JS; Schray M; Mitchell C; Sherman A; Chen P; Brabbins DA
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):527-35. PubMed ID: 12243832
[TBL] [Abstract][Full Text] [Related]
20. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP
Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
